SCHEMBL283464

SCHEMBL283464

Cc1cc(O)c(C)c(O)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
MAPT P10636 5/20 0.46
KDM4E B2RXH2 4/20 0.46
LMNA P02545 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 2/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2D6 P10635 1/20 0.43
G6PD P11413 1/20 0.43
PKM P14618 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29372751 0.82 ACHE (0.48) ACHECA1CA2MAPTKDM4E
SCHEMBL2562811 0.82 ACHE (0.48) ACHECA1CA2MAPTKDM4E
SCHEMBL29899692 0.82 ACHE (0.48) ACHECA1CA2MAPTKDM4E
SCHEMBL70458 0.82 ACHE (0.48) ACHECA1CA2MAPTKDM4E
SCHEMBL68397 0.82 ACHE (0.48) ACHECA1CA2MAPTKDM4E
SCHEMBL21002133 0.80 ACHE (0.46) ACHECA1CA2MAPTKDM4E
SCHEMBL2220478 0.79 SELL (0.50) ACHECA1CA2MAPTKDM4E
SCHEMBL634558 0.79 SELL (0.50) ACHECA1CA2MAPTKDM4E
SCHEMBL5680954 0.79 CA1 (0.50) ACHECA1CA2MAPTKDM4E
SCHEMBL3195155 0.78 ACHE (0.56) ACHECA1CA2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11520083-B2 Member, imaging apparatus, and method for producing member CANON KABUSHIKI KAISHA (JP) 2022-12-06 US claimed
CN-111978224-B Sulfur-containing monomolecular resin and photoresist composition thereof 中国科学院理化技术研究所 2022-10-28 CN claimed
CN-112142955-B Adamantane-polyphenol oligomer, photoresist composition and application thereof 中国科学院理化技术研究所 2022-04-29 CN claimed
JP-9188642-A None JP disclosed
WO-2026105630-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, RESIST UNDERLAYER FILM, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE 日産化学株式会社 2026-05-21 WO disclosed
WO-2026105628-A1 COMPOSITION FOR FORMING RESIST UNDERLAYER FILM, RESIST UNDERLAYER FILM, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE 日産化学株式会社 2026-05-21 WO disclosed
US-20260118765-A1 RESIST UNDERLAYER FILM FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2026-04-30 US disclosed
US-12601972-B2 Resist underlayer film-forming composition with suppressed degeneration of crosslinking agent NISSAN CHEMICAL CORPORATION (JP) 2026-04-14 US disclosed
EP-4692943-A1 RESIST UNDERLAYER FILM FORMING COMPOSITION Nissan Chemical Corporation (JP) 2026-02-11 EP disclosed
US-20260022203-A1 SELF-CROSSLINKABLE POLYMER AND RESIST UNDERLAYER FILM FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2026-01-22 US disclosed
EP-4679176-A1 RESIST UNDERLAYER FILM-FORMING COMPOSITION Nissan Chemical Corporation (JP) 2026-01-14 EP disclosed
US-5611889-A DISCOLORATION INHIBITION; BRIGHTENING; PAPERMAKING PULP AND PAPER RESEARCH INSTITUTE OF CANADA (CA) 1997-03-18 US disclosed
US-4871762-A CARDIOVASCULAR DISORDERS, ANTIALLERGENS SANKYO COMPANY, LIMITED (JP) 1989-10-03 US disclosed
EP-0157603-B1 1, 3-BENZOXATHIOLE DERIVATIVES, THEIR USE AND THEIR PREPARATION SANKYO COMPANY LIMITED (JP) 1989-09-06 EP disclosed
US-4691027-A FOR TREATING CICULATORY DISORDERS AND ALLERGIES SANKYO COMPANY, LIMITED (JP) 1987-09-01 US disclosed
US-4584363-A Thermoset resins based on bicyclic amide acetal modified unsaturated polycarboxylic acids, polyisocyanates and vinyl monomers ASHLAND OIL, INC. (US) 1986-04-22 US disclosed
EP-0157603-A2 1, 3-Benzoxathiole derivatives, their use and their preparation SANKYO COMPANY LIMITED (JP) 1985-10-09 EP disclosed
US-4067933-A OXIDATION RESISTANCE THE GOODYEAR TIRE & RUBBER COMPANY (US) 1978-01-10 US disclosed
US-4024206-A DIMETHYL METHYL PHOSPHONATE VISTRON CORPORATION (US) 1977-05-17 US disclosed
US-3959221-A OXIDATIVE DEGRADATION THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118765-A1 RESIST UNDERLAYER FILM FORMING COMPOSITION ASH2L, ASIC1, RPA1 ACHE 4483/4885CA1 427/4885CA2 877/4885
US-20260022203-A1 SELF-CROSSLINKABLE POLYMER AND RESIST UNDERLAYER FILM FORMING COMPOSITION SMC2, SMC4, SMC3 ACHE 2839/4885CA1 1692/4885CA2 3757/4885
US-12601972-B2 Resist underlayer film-forming composition with suppressed degeneration of crosslinking agent BHMT, AADAT, PNMT ACHE 2158/4885CA1 4818/4885CA2 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.